Rocephin and Dermal cyst - a phase IV clinical study of FDA data

Summary:

Dermal cyst is reported as a side effect among people who take Rocephin (ceftriaxone sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Celebrex, and have Bone loss.

The phase IV clinical study analyzes which people have Dermal cyst when taking Rocephin. It is created by eHealthMe based on reports of 15,458 people who have side effects when taking Rocephin from the FDA, and is updated regularly.

What is Rocephin?

Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.

What is Dermal cyst?

Dermal cyst is found to be associated with 537 drugs and 521 conditions by eHealthMe. Check the latest studies of Dermal cyst.

On Jul, 15, 2026

15,458 people reported to have side effects when taking Rocephin.
Among them, 39 people (0.25%) have Dermal cyst.

Among these 39 people:

How long have people been on Rocephin when they have Dermal cyst? *

What is the gender of people who have Dermal cyst when taking Rocephin? *

female: 48.72 %
male: 51.28 %

What is the age of people who have Dermal cyst when taking Rocephin? *

What are other drugs people take besides Rocephin? *

What are other side effects people have besides Dermal cyst? *

Pain: 37 people, 94.87%
Stress And Anxiety: 37 people, 94.87%
Pleural Effusion (water on the lungs): 36 people, 92.31%
Thrombocytopenia (decrease of platelets in blood): 36 people, 92.31%
Osteonecrosis Of Jaw (death of bone of jaw): 32 people, 82.05%
Back Pain: 28 people, 71.79%
Cardiac Failure Congestive: 26 people, 66.67%
High Blood Pressure: 26 people, 66.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 26 people, 66.67%
Sepsis (a severe blood infection that can lead to organ failure and death): 26 people, 66.67%

What are the existing conditions these people have? *

Neoplasm Malignant (cancer tumour): 12 people, 30.77%
Bone Loss: 12 people, 30.77%
Osteoporosis (bones weak and more likely to break): 5 people, 12.82%
Broken Bone: 5 people, 12.82%
Bone Disorder: 4 people, 10.26%
Pulmonary Amyloidosis (deposition of amyloid in the lungs): 2 people, 5.13%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 5.13%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.13%
Dyskinesia (abnormality or impairment of voluntary movement): 2 people, 5.13%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 2.56%

* Approximation only. Some reports may have incomplete information.

Do you take Rocephin and have Dermal cyst?

- Check whether Dermal cyst is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rocephin:

Rocephin (15,665 reports)

Dermal cyst treatments and more:

Dermal cyst (3,605 reports)

Browse all side effects of Rocephin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermal cyst:

Dermal cyst (537 drugs)

Browse all the conditions that are associated with Dermal cyst:

Dermal cyst (521 conditions)

Related publications that referenced our studies

Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium (the active ingredients of Rocephin) and Rocephin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.